Chemical Structure (Turalio 01)
Turalio Capsule
Product Images NDC 65597-407
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Turalio (NDC 65597-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Daiichi Sankyo Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Turalio 02)
The text describes a comparison between two treatments, TURALIO and Placebo, with a sample size of 45 and 43 respectively. The table shows the improvement of patients in relation to their baseline in percent, and their tumor response, labeled as either responders or non-responders. The evaluation method is the RECIST (Response Evaluation Criteria in Solid Tumors) v1.1.*
Principal Display Panel (125 mg Capsule Bottle Carton)
Yuralio (pexidartinib) is a medication that comes in capsule form. Each capsule contains 1359mg of poidarbin hydrochloride and Salvelan 125mg of poidarbin. It is recommended to be taken with a low-fat meal. The trademark of Yuralio belongs to Daichi Sankyo Company, Ltd. The medicine is manufactured by the same company and comes in a pack of 120 capsules. The recommended dosage should be prescribed. Lot 0000 EXP YYYY-AR-DD is the information given for the lot number. The text also includes storage instructions and cautions about keeping it out of reach of children. The rest of the information is illegible.*
Principal Display Panel (125 mg Capsule Bottle Carton)
Yuralio (pexidartinib) is an oral medication that comes in a capsule form. Each capsule contains 1359 mg of pexidartinib hydrochloride, equivalent to 125 mg of pexidartinib. This medication should be taken with a low-fat meal as directed by a physician. The recommended dosage is on the prescription information. The medication should be stored between 20°C to 25°C (68°F to 77°F) in a closed container with the desiccant undisturbed. It is a registered trademark of Daichi Sankyo Company, Li. The pharmacist should dispense the medication guide to each patient.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
